Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06008093 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 280 participants |
| Active Locations | 105 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 27, 2025 (Oct 27, 2025) |
As of March 2, 2026: Clinical trial NCT06008093 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 105 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06008093 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 105 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06008093 was last updated Oct 27, 2025 (October 27, 2025). HelloStudys verifies this status automatically.